LL5 |Liraglutide| 5mg/vial，10vial/kit| >99% Purity
Price range: $138.00 through $190.00
Chemical Specifications
| Product Name | LL5(Liraglutide) |
|---|---|
| CAS Number | 204656-20-2 |
| Molecular weight | 3751.2 Da |
| Purity (HPLC) | ≥ 99.0% |
| Appearance | White Lyophilized Powder |
| Storage | Store at -20°C (Protect from light and moisture) |
🧬
Basic Introduction
Liraglutide is a long‑acting fatty acid‑modified GLP‑1 agonist that mimics endogenous GLP‑1 secreted by intestines after meals.
Native human GLP‑1 is rapidly degraded by DPP‑4 enzyme within minutes after secretion, while structural modification of liraglutide resists enzymatic breakdown and binds albumin for slow sustained release, continuously activating GLP‑1 receptors throughout the day.
It exerts multiple effects including glucose‑dependent hypoglycemia, delayed gastric emptying, suppression of hypothalamic appetite center, pancreatic β‑cell protection, vascular endothelial protection and visceral fat reduction.
Different from GH secretagogues (CJC, Ipamorelin, Sermorelin), liraglutide targets the gut‑glucose‑appetite metabolic axis with core strengths in weight loss and glycemic control. It can be synergistically stacked with GH secretagogues, repair peptides and NAD+ coenzyme to amplify metabolic and anti‑aging benefits.
Why Use Liraglutide?
🛡️
Dual indications for weight loss & glycemic control with comprehensive metabolic improvement
One of few GLP‑1 agents approved for both diabetes treatment and long‑term weight management, suitable for diabetic patients and simple obese individuals.
✨
Glucose‑dependent hypoglycemic effect with extremely low hypoglycemia risk
Unlike insulin and sulfonylureas, it does not force insulin secretion unconditionally; severe hypoglycemia rarely occurs when used alone.
⚛️
Long‑acting once‑daily injection for high compliance
13‑hour extended half‑life, only one subcutaneous injection at fixed time daily without frequent dosing.
⚖️
Preferential visceral fat breakdown to resolve root of metabolic obesity
Conventional dieting only reduces subcutaneous fat; liraglutide selectively cuts visceral fat to fundamentally relieve insulin resistance, fatty liver and dyslipidemia.
⏳
Additional cardiovascular protective benefits
Most weight‑loss drugs offer no cardiac protection; liraglutide clearly reduces cardiovascular and cerebrovascular event risk, ideal for patients complicated with hypertension and hyperlipidemia.
🔬
Delay gastric emptying to sustain satiety without extreme calorie restriction
Naturally suppresses appetite, easy for long‑term adherence with low weight rebound risk.
Mechanism of Action
- Glucose‑dependent insulin secretionOnly stimulates pancreatic β‑cell insulin release when blood glucose elevates; no insulin‑stimulating activity under normoglycemia, drastically cutting severe hypoglycemia risk of conventional hypoglycemic agents.
- Suppress glucagon secretionReduce hepatic glucagon release under hyperglycemia, inhibit liver glycogenolysis and gluconeogenesis to lower endogenous glucose output and stabilize fasting & postprandial blood glucose.
- Delay gastric emptying and prolong satietySlow gastrointestinal peristalsis and nutrient absorption, significantly extend fullness duration, reduce total daily calorie intake and curb food cravings naturally.
- Downregulate hypothalamic appetite signalingAct on brain arcuate nucleus to reduce hunger signals and binge eating impulses, especially cravings for high‑sugar and refined high‑calorie carbohydrates.
- Protect pancreatic β‑cells and slow islet function declineAlleviate oxidative stress and apoptosis of pancreatic cells; long‑term administration preserves native insulin secretion capacity and delays progression of type 2 diabetes.
- Improve systemic metabolic inflammation and reduce visceral fatInhibit pro‑inflammatory adipokines secreted by visceral fat, accelerate abdominal visceral lipolysis, relieve insulin resistance, dyslipidemia and hepatic lipid accumulation.
- Vascular endothelial protection & cardiovascular benefitsImprove endothelial function, lower systolic blood pressure and LDL cholesterol, reducing risks of myocardial infarction, stroke and other cardiovascular events.
Core Efficacy
1 Weight & Fat Loss with Preferential Visceral Fat Reduction
- Sustainably reduce total calorie intake, gradually lower body weight and body fat percentage, significantly shrink waist circumference.
- Target breakdown of abdominal visceral fat, relieve metabolically harmful central obesity and chronic inflammation triggered by fat accumulation.
- Reduce excess subcutaneous fat while maximally preserving lean muscle mass to avoid sagging skin after weight loss.
2 Glycemic Control, Improve Type 2 Diabetes & Insulin Resistance
- Stabilize fasting and postprandial blood glucose, markedly reduce glycated hemoglobin HbA1c.
- Boost whole‑body insulin sensitivity and relieve impaired glucose tolerance caused by obesity and aging.
- Protect pancreatic islet function and slow aggravation of diabetic progression.
3 Cardiovascular Protection, Reduce Metabolic Complication Risks
- Mild blood pressure reduction and lipid regulation (lower triglycerides and LDL cholesterol).
- Repair vascular endothelium, mitigate chronic vascular inflammation and reduce atherosclerosis risk.
- Officially proven to lower major adverse cardiovascular event risk in diabetic patients with cardiovascular disease.
4 Hepatic Metabolic Improvement, Alleviate Non‑Alcoholic Fatty Liver Disease
5 Relieve Eating Disorders & Emotional Binge Eating
🧪 What’s In The Vial
- Chemical Classification: Long‑acting GLP‑1 receptor agonist, modified human glucagon‑like peptide‑1
- CAS Number: 204656-20-2
- Base: 100% Sterile SWFI
- State: White Lyophilized Powder
- Structural Feature: Native GLP‑1 modified with fatty acid side chain, reversibly binds albumin to greatly extend half‑life
👩🔬 Primary Research Applications
- Obesity & metabolic syndrome animal models: Experiments on weight loss, visceral lipolysis and insulin resistance intervention
- Type 2 diabetes basic research: Pancreatic β‑cell protection, glycemic regulation and HbA1c improvement
🔗 Best Paired With
Synergy Mechanism
Liraglutide systemically inhibits fat synthesis; CND5 adipose‑homing peptide targets visceral fat to amplify lipolysis; Sermorelin elevates GH to further break down visceral fat and relieve hepatic lipid accumulation, designed for severe abdominal adiposity, fatty liver and insulin resistance.
AS MENTIONED ON
Real People, Real Transformations
16 weeks
DURATION
+18 lbs
LEAN MASS
-7%
BODY FAT
“RESEARCHER NOTES: This subject struggled to gain weight for years. Upon introducing the CJC-1295 / Ipamorelin blend protocol, the results clicked. Muscle fullness improved significantly, and recovery time was cut in half.”
— Liam, age 24
12 weeks
DURATION
+14 lbs
LEAN MASS
-9%
BODY FAT
“I’d been training for years but never really saw the results. Once I started my IGF-1 LR3 and BPC-157 protocol, everything clicked. The lean tissue gains and joint recovery are unreal.”
— Marcus, age 30
12 weeks
DURATION
+10 lbs
LEAN MASS
-8%
BODY FAT
“I wanted muscle tone without ‘bulking’. Adding Ipamorelin to my regimen allowed me to train consistently. The mirror shows lean changes I couldn’t achieve with diet alone.”
— Sarah, age 29
12 weeks
DURATION
-28 lbs
LEAN MASS
-15%
BODY FAT
“RESEARCHER NOTES: Targeted a stubborn fat protocol with Tirzepatide. This subject experienced a massive reduction in visceral fat within the first 6 weeks without losing lean mass.”
— David, age 45
16 weeks
DURATION
-24 lbs
LEAN MASS
-12%
BODY FAT
“The fat just wouldn’t budge around my mid-section. Once I introduced Semaglutide into my research protocol, the weight loss was immediate, sustainable, and my cravings disappeared.”
— Emily, age 32
12 weeks
DURATION
-35 lbs
LEAN MASS
-18%
BODY FAT
“By targeting metabolic efficiency with Tesamorelin and AOD-9604, muscle tissue was preserved while stubborn visceral fat melted away. Completely different physique.”
— Daniel, age 41
8 weeks
DURATION
+45%
CLARITY
+60%
ELASTICITY
“I struggled with persistent redness and uneven texture. After adopting a GHK-Cu peptide protocol, the inflammation vanished. My skin literally glows from the inside.”
— Chloe, age 27
12 weeks
DURATION
+55%
REPAIR
+30%
YOUTHFUL
“My face looked permanently tired. Working with Epithalon and GHK-Cu was a game changer. Pores minimized, fine lines reduced, and I’m sleeping deeper too.”
— Jason, age 36
Trusted by happy customers
TrustScore 5.00
30 Reviews
30 reviews for LL5 |Liraglutide| 5mg/vial，10vial/kit| >99% Purity
Free Shipping
On all orders
Secure Checkout
SSL encrypted
24/7 Support
Always available
Discreet Packaging
Plain packaging
Related products
-
Sale!
Research PeptidesVIP5 | VIP | 5mg10vials | >99% Purity
$79.00 Select options This product has multiple variants. The options may be chosen on the product page -
Sale!
Research PeptidesSMO5 |Sermorelin| 5mg*10vials | >99% Purity
$63.00 Select options This product has multiple variants. The options may be chosen on the product page -
Sale!
Research PeptidesSX5 |Semax| 5mg*10vials | >99% Purity
$31.50 Select options This product has multiple variants. The options may be chosen on the product page -
Sale!
Research PeptidesP41|PT-141| 10 mg/vial，10vial/kit| >99% Purity
$54.99 Select options This product has multiple variants. The options may be chosen on the product page
Roxie P. –
My lab focuses on insulin resistance and visceral fat reduction animal models. This lipid-modified Liraglutide delivers stable long-acting metabolic effects that short-chain GLP peptides cannot replicate, and ultra-high purity eliminates impurity interference on quantitative insulin measurement readouts.
Gideon Tarrant –
I ran blinded parallel comparative endocrine trials with Liraglutide sourced from six different manufacturers, and this LL5 lyophilized variant delivers far superior solubility with minimal powder residue stuck to inner glass vial walls. Slow circular swirling achieves full dissolution; harsh violent shaking fractures the lipidated peptide backbone and skews quantitative glucose-lowering assay readouts.
Cian V. –
Cross-batch consistency is exceptional; glycemic response curves from kits ordered four months apart are nearly identical. I no longer need to recalibrate all assay parameters every time a new bulk shipment arrives thanks to uniform powder composition and fixed purity standards.
Marlow H. –
I test lipidated GLP-1 analogs side by side, and this LL5 Liraglutide powder has far less wall adhesion after reconstitution than competitors. The uniform lyophilized texture lets me recover nearly full 5mg labeled mass for precise low-dose cell culture testing without extra corrective dosing calculations.
Juno M. –
The gold flip-off crimp caps maintain airtight sealing even after dozens of repeated syringe punctures. Lab ambient moisture cannot seep into partially used vials stored long-term at -20°C, so leftover dry powder never absorbs humidity and clumps over months of freezer storage.
Querida Voss –
Consistent certified ≥99% HPLC purity, clear strict low-temperature dark dry storage guidelines, dual flexible vial dosage sizes and rock-solid cross-batch uniformity make LL5 my exclusive Liraglutide peptide supplier. I place monthly recurring bulk restock orders for my long-term glycemic control, insulin sensitivity and adipocyte metabolism lab research projects, with zero fluctuation in powder solubility or biological activity between every shipment.
Peregrine Morris –
Advanced industrial recrystallization lyophilization creates ultra-fine free-flowing white powder without hard compacted sediment chunks settled at the vial bottom. When I only require tiny microgram-level samples for early preliminary glycemic screening assays, I can extract partial dry powder without fully reconstituting the entire vial to conserve expensive LL5 lab stock.
Marlow Knight –
I conduct random blind HPLC spot quality audits on randomly selected vials from every shipment batch, every tested sample consistently hits the advertised ≥99% purity threshold with no unknown impurity peaks visible on chromatogram outputs. Complete batch purity certification documents ship alongside every order, fully compliant for university lab audit and academic research manuscript submission standards.
Zoraida S. –
I reached out to support requesting separate HPLC purity reports for every batch I purchased. They delivered complete chromatogram files rapidly, each document clearly confirms ≥99% purity with no detectable peptide degradation fragments, which meets my institute’s strict research archive rules.
Vada M. –
I once left an unopened vial on my lab bench at room temperature for two full days by accident. Post-testing showed visible powder clumping and weakened insulin-stimulating activity, reinforcing that constant -20°C dark storage is mandatory for long-term stock preservation.
Hestia Voss –
Two flexible dosage specifications (5mg, 10mg per vial) fully cover all stages of my research workflow. The standard 5mg single vial fill size is calibrated for small preliminary glycemic screening experiments; I only reconstitute one vial per testing cycle to eliminate waste of diluted Liraglutide that rapidly loses biological potency once exposed to ambient light and room temperature.
Lavinia G. –
I run continuous 7-day refrigerated cell culture assays with reconstituted Liraglutide solution. When properly shielded from light after mixing, the liquid stays fully transparent and retains steady incretin receptor activation potency for nearly a full week without precipitation.
Ewan Ray –
Liraglutide serves as my core research peptide for glucose homeostasis, insulin secretion and visceral fat reduction pathway studies. Its lipid-modified structure delivers prolonged in-vivo incretin activation, and all glass vials arrived fully intact with zero cracks or leakage during cross-border international lab shipping.
Kyran B. –
Buying this 10-vial bulk kit during the limited-time sale slashes my quarterly peptide budget significantly compared to purchasing single vials repeatedly. For labs running long-term glucose homeostasis trials, the bulk pack offers massive time and cost savings year-round.
Niven Powell –
International bulk shipping packaging uses custom individual shock-absorbent foam dividers to isolate each glass vial and prevent collision breakage during long overseas transit. I’ve placed four separate cross-border bulk orders so far, and zero vials arrived cracked, chipped, leaking or contaminated upon delivery to my research facility.
Talia L. –
The two size options (5mg and 10mg per vial) perfectly split my lab workflow: small 5mg vials for low-volume cell culture screening, larger 10mg vials for full-scale in-vivo rodent metabolic trials, no need to mix and match different supplier products.
Elowen T. –
For early-stage micro-dose preliminary screening, the loose free-flowing crystalline powder allows me to scrape tiny dry powder samples without fully reconstituting an entire vial. This drastically cuts peptide waste and extends each bulk kit’s usable testing lifespan.
Sterling F. –
UV exposure quickly triggers yellow discoloration and loss of lipidated peptide activity, so I store all unopened vials inside fully opaque freezer storage bins. After three months of undisturbed -20°C storage, every vial’s powder remains bright white with zero signs of oxidation.
Torin A. –
I’ve ordered this LL5 Liraglutide six times for cross-border lab research projects. Every shipment adds extra thick bubble wrap and individual foam slots for each glass vial, zero vials arrived cracked or leaked even with rough international courier handling.
Kael Frost –
The optimized industrial lyophilization process drastically reduces peptide adhesion to inner glass vial walls after dissolution. I recover nearly the full labeled 5mg powder mass from every vial, eliminating major dosing inaccuracies in quantitative GLP-1 receptor binding and insulin resistance signaling research.
Wesley B. –
I’ve tested three competing Liraglutide suppliers in blinded parallel activity trials, and LL5 produces the most steady, reproducible GLP-1 activation data across all test groups. The lack of hidden impurities ensures my long-term metabolic research data stays consistent and publishable without extra purification steps.
Daisie Pruitt –
Each vial inside the standard 5mg×10 bulk kit holds ultra-fine free-flowing white lyophilized powder that dissolves fully into sediment-free crystal clear liquid after slow gentle swirling. The hermetic gold aluminum flip cap forms a complete humidity barrier, so powder never clumps even after repeated syringe punctures to draw tiny partial aliquots for pancreatic beta cell culture testing.
Rhys W. –
I once mistakenly stored a sealed vial in a frost-free freezer with minor daily temperature fluctuations for over a month. The powder retained its original white color and full biological activity, showing the lyophilization process provides mild tolerance against brief storage temperature shifts.
Ulric R. –
Beyond core glucose regulation research, I also use this Liraglutide for adipocyte differentiation in-vitro trials. Its consistent lipidated peptide structure avoids unexpected cellular signaling interference common with lower-purity generic alternatives on the market.
Oriina Quin –
This lipidated Liraglutide peptide expands my lab’s research scope far beyond basic weight loss and glucose control analysis. I also utilize it for pancreatic beta cell survival in-vitro cell culture trials, and its uniform lyophilized structure avoids unexpected cellular signaling interference common with low-purity generic alternatives available on the market.
Lavinia Nash –
A lab trainee accidentally left an unopened LL5 Liraglutide vial on the lab bench at room temperature for three full days. Post-testing showed severe powder clumping and drastically weakened glucose-regulating biological activity, clearly proving strict dark frozen -20°C storage rules cannot be overlooked for long-term stock preservation.
Briar Oakes –
This LL5 Liraglutide is pure white lyophilized lipidated GLP-1 peptide powder with HPLC purity ≥99%. Long-term lab preservation requires fully sealed vials stored at -20°C and fully shielded from light and moisture. Constant dark frozen storage stabilizes its fatty-acid modified polypeptide chain to prevent hydrolysis, retaining consistent insulin-regulating and adipocyte lipolysis activity for glycemic metabolism research over multiple months.
Fioren Sloane –
The listed CAS registry number and 3751.2 Da molecular weight align perfectly with authoritative peer-reviewed biochemical reference databases. This lab-grade LL5 contains no inert bulking fillers or fragmented peptide fragments, and steady -20°C dark storage blocks photo-oxidation that damages its GLP-1 active lipidated chain.
Jolene York –
Prolonged UV light exposure triggers gradual yellow discoloration and molecular breakdown of Liraglutide powder, so I store all unopened sealed vials inside fully opaque freezer storage bins. After two full months of uninterrupted -20°C frozen storage, the powder stays bright pure white, and reconstituted peptide liquid never develops cloudiness or solid precipitates over multi-day refrigerated testing cycles.
Ignis Wade –
This 10-vial bulk pack includes a steep limited-time promotional discount that drastically cuts my monthly lab raw material expenditure. Vial-to-vial powder texture, peptide concentration and HPLC purity show zero measurable deviation, making all my incretin signaling experimental data highly repeatable across separate test batches.